~~<i id='5985F8351E'><strike id='5985F8351E'><tt id='5985F8351E'><pre id='5985F8351E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：entertainment 2025-09-29 16:35:47 - browse：57

A traditional Chinese medicine compound used for cardiac benefits might help reduce the incidence of major adverse cardiac and cerebrovascular events and even cardiac death rates, according to a new study published Tuesday in the Journal of the American Medical Association.

However, some outside experts expressed skepticism about the result.

Tongxinluo — which means “to open (tong) the network (luo) of the heart (xin)” in Mandarin — is a traditional Chinese medicine compound made out of a mixture of powders and extracts from plants, centipedes, cicadas, and other sources.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Will Ozempic

hotspot

focus

explore

knowledge

leisure time

AlexHogan/STATEachyear,STATsetsouttocelebratetheunheraldedheroesofscienceandmedicine,poringoverhundr

WSS

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Lilly’s weekly insulin works as well as daily products, new studies show

WuXi Biologics beefs up its lobbying operation

STAT Summit: Michael J. Fox on progress in Parkinson's research

Obesity drug from Roche shows promise in early study

Galapagos to make CAR

explore

explore

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

UnitedHealth’s board chair also owns a personal investment firm

At least 13 dead in Texas as scorching temps continue

Solve the antibiotic resistance crisis with preventive drugs

Virginia high school admissions case could be legal follow

HHS leader on health, climate change and biopharma emissions

Alkermes shareholders re

Lilly’s weekly insulin works as well as daily products, new studies show

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Studies point to risks of excluding people with obesity from drug trials

focus

Beam Therapeutics to lay off 20% of its staff, re

The EU Joint Clinical Assessment needs to live up to its promise

As H5N1 spreads in cows, experts warn against drinking raw milk

Novo Nordisk testing Wegovy against alcohol

HHS leader on health, climate change and biopharma emissions

STAT Summit: GSK CEO on pharma giant's new direction

focus

explore

knowledge

leisure time